{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:59:01Z","timestamp":1790179141420,"version":"4.1.0"},"reference-count":38,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2011,1,25]],"date-time":"2011-01-25T00:00:00Z","timestamp":1295913600000},"content-version":"vor","delay-in-days":24,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Dermatology"],"published-print":{"date-parts":[[2011,1]]},"abstract":"<jats:p>\n                    <jats:bold>Abstract:\u2002<\/jats:bold>\n                    We present 5 cases of eczema herpeticum in patients with severe recalcitrant atopic dermatitis to illustrate the range of possible clinical findings and supporting laboratory data that can obscure the diagnosis and complicate treatment. Major issues include: the need for aggressive laboratory evaluation (molecular diagnostics, viral cultures, skin biopsy, serology); the possibility of recurrent or chronic infection; the value of empiric antiviral therapy; the possibility of infection with thymidine\u2010kinase resistant strains; and the importance of achieving control over the dermatitis with nonmyelosuppressive immunomodulating agents such as intravenous immunoglobulin or interferon gamma for dermatitis that requires systemic treatment.\n                  <\/jats:p>","DOI":"10.1111\/j.1525-1470.2010.01356.x","type":"journal-article","created":{"date-parts":[[2011,1,25]],"date-time":"2011-01-25T01:10:44Z","timestamp":1295917844000},"page":"46-52","source":"Crossref","is-referenced-by-count":31,"title":["The Clinical Spectrum and Therapeutic Challenge of Eczema Herpeticum"],"prefix":"10.1111","volume":"28","author":[{"given":"Stephanie","family":"Frisch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine C.","family":"Siegfried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,1,25]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0207"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09229.x"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2005.12.1345"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.04.044"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.5.670"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1992.03490180073029"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2007.03337.x"},{"key":"e_1_2_7_9_2","first-page":"1124","article-title":"Performance of two commercial glycoprotein G\u2010based enzyme immunoassays for detecting antibodies to herpes simplex viruses 1 and 2 in children and young adolescents","volume":"9","author":"Leach CT","year":"2002","journal-title":"Clin Diagn Lab Immunol"},{"key":"e_1_2_7_10_2","volume-title":"Laboratory diagnosis of viral infections","author":"Lennette EH","year":"1999"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2007.04.065"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(18)30201-8"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197707142970201"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(95)91808-6"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2003.00744.x"},{"key":"e_1_2_7_16_2","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1128\/jcm.29.3.466-469.1991","article-title":"Evaluation of five monoclonal antibody\u2010based kits or reagents for the identification and culture confirmation of herpes simplex virus","volume":"29","author":"Lipson SM","year":"1991","journal-title":"J Clin Microbiol"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/1096-9071(200101)63:1<52::AID-JMV1007>3.0.CO;2-H"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.41376"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.04.063"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-0960.2008.00451_1.x"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03241.x"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2006.07686.x"},{"key":"e_1_2_7_23_2","article-title":"Topical calcineurin inhibitors compromise stratum corneum integrity, epidermal permeability and antimicrobial barrier function","author":"Minjeong K","year":"2009","journal-title":"Exp Dermatol"},{"key":"e_1_2_7_24_2","first-page":"73","article-title":"Eczema molluscatum in tacrolimus treated atopic dermatitis","volume":"14","author":"Wetzel S","year":"2004","journal-title":"Eur J Dermatol"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2007.00480.x"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.4103\/0378-6323.41378"},{"key":"e_1_2_7_27_2","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1542\/peds.110.1.e2","article-title":"Efficacy and safety of pimecrolimus cream in the long\u2010term management of atopic dermatitis in children","volume":"110","author":"Ulrich W","year":"2002","journal-title":"Pediatrics"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(01)00003-1"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1067\/S0190-9622(03)00896-X"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sder.2008.04.002"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2009.05128.x"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0905506"},{"key":"e_1_2_7_33_2","first-page":"211","article-title":"Topics in primary care medicine: management of herpes simplex and varicella\u2010zoster virus infections","volume":"166","author":"Erlich K","year":"1997","journal-title":"West J Med"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/39.2.119"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200203030-00004"},{"key":"e_1_2_7_36_2","first-page":"187","article-title":"Recombinant interferon gamma therapy for atopic dermatitis","volume":"1","author":"Hanifen JM","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.104793"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.1999.14.1.63"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.0307-6938.2001.00955.x"}],"container-title":["Pediatric Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1525-1470.2010.01356.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1525-1470.2010.01356.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T04:21:47Z","timestamp":1698726107000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1525-1470.2010.01356.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["10.1111\/j.1525-1470.2010.01356.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1525-1470.2010.01356.x","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.8430956.8911055","asserted-by":"object"}]},"ISSN":["0736-8046","1525-1470"],"issn-type":[{"value":"0736-8046","type":"print"},{"value":"1525-1470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}